- Report
- April 2023
- 249 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- July 2022
- 162 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- August 2022
- 281 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
- Report
- May 2023
- 270 Pages
Global
From €2275EUR$2,499USD£1,932GBP
€3249EUR$3,570USD£2,760GBP
The Antacid market is a segment of the Over the Counter (OTC) Drugs industry. Antacids are used to treat symptoms of acid reflux, heartburn, and indigestion. They are available in a variety of forms, including tablets, liquids, and chewable gummies. Antacids are generally safe and effective, and can be purchased without a prescription.
The Antacid market is highly competitive, with a wide range of products available from both large and small companies. Many of the products are marketed as being fast-acting and long-lasting, and some are formulated to provide additional benefits such as relief from gas and bloating.
Some of the companies in the Antacid market include GlaxoSmithKline, Pfizer, Bayer, Johnson & Johnson, Novartis, and Procter & Gamble. Show Less Read more